Development and validation of a LC-MS/MS method for ripretinib and its metabolite: example of a journey from laboratory bench to routine application with a greenness assessment
Preprint
Abstract
Therapeutic drug monitoring of protein kinase inhibitors is a widely practiced worldwide. Based on the example of ripretinib dosage requested by a clinician, we detailed the process of method development, using a literature-based approach while ensuring the sustainability of the method to be as environmentally friendly as possible. Therefore, an UPLC-MS/MS method for ripretinib and its active metabolite was optimized and validated using the corresponding stable isotopic internal standards in human plasma. The procedure has employed mobile phase mixture of water with 1% acetic acid and 0.1% formic acid, and acetonitrile. Positive electrospray ionization was performed coupling with multiple reaction monitoring of m/z 510.4→417.4 and 510.4→389.4 for ripretinib, and 496.3→403.3 and 496.3→375.3 for N-desmethyl-ripretinib. The method was successfully validated according the current version of ICH Guideline provided by the EMA. The greenness assessment score of this procedure was evaluated and compared with previously published approaches using the AGREE metric. The validated UPLC-MS/MS method successfully monitored ripretinib and its metabolite concentrations in clinical and pre-clinical models.Keywords
This publication has 23 references indexed in Scilit:
- Green analytical chemistry metrics for evaluating the greenness of analytical proceduresJournal of Pharmaceutical Analysis, 2024
- Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug–Drug Interaction Study in RatsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2023
- Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or AneurysmsJAMA Oncology, 2021
- Ripretinib: First ApprovalDrugs, 2020
- Limitations of deuterium‐labeled internal standards for quantitative electrospray ionization mass spectrometry analysis of fatty acid metabolitesRapid Communications in Mass Spectrometry, 2020
- Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA VariantsCancer Cell, 2019
- Bioanalytical method development and validation: Critical concepts and strategiesJournal of Chromatography B, 2017
- Programming with ggplot22016
- Evaluation of 13C- and 2H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography–tandem mass spectrometryJournal of Chromatography A, 2014
- Does a stable isotopically labeled internal standard always correct analyte response?Journal of Pharmaceutical and Biomedical Analysis, 2007